MY6400075A - Improvements in or relating to 6-methyl-3-oxo-delta 4,6-steroid compounds - Google Patents
Improvements in or relating to 6-methyl-3-oxo-delta 4,6-steroid compoundsInfo
- Publication number
- MY6400075A MY6400075A MY75/64A MY6400075A MY6400075A MY 6400075 A MY6400075 A MY 6400075A MY 75/64 A MY75/64 A MY 75/64A MY 6400075 A MY6400075 A MY 6400075A MY 6400075 A MY6400075 A MY 6400075A
- Authority
- MY
- Malaysia
- Prior art keywords
- oxo
- delta
- relating
- methyl
- steroid compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB35428/58A GB870286A (en) | 1958-11-04 | 1958-11-04 | Improvements in or relating to 6-methyl-3-oxo-í~-steroid compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY6400075A true MY6400075A (en) | 1964-12-31 |
Family
ID=10377599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MY75/64A MY6400075A (en) | 1958-11-04 | 1964-12-30 | Improvements in or relating to 6-methyl-3-oxo-delta 4,6-steroid compounds |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US3356573A (h) |
| BE (1) | BE584312A (h) |
| CH (1) | CH379493A (h) |
| DE (1) | DE1120446B (h) |
| FR (2) | FR1333711A (h) |
| GB (1) | GB870286A (h) |
| MY (1) | MY6400075A (h) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1210819B (de) * | 1962-03-23 | 1966-02-17 | Ayerst Mckenna & Harrison | Verfahren zur Herstellung von in 17alpha-Stellung alkylierten Pregnanderivaten |
| DE1201342B (de) * | 1963-03-05 | 1965-09-23 | Olin Mathieson | Verfahren zur Herstellung von Steroiden |
| US4370321A (en) * | 1976-09-01 | 1983-01-25 | Mead Johnson And Company | Progestational adjuvant therapy |
| US4346037A (en) * | 1981-07-10 | 1982-08-24 | The Upjohn Company | Base catalyzed acylation with enol esters |
| US5338732A (en) * | 1991-06-18 | 1994-08-16 | Bristol-Myers Squibb Company | Megestrol acetate formulation |
| BR9908592A (pt) * | 1998-03-11 | 2001-04-24 | Endorech Inc | Processo para inibir a atividade de 17ß-hidroxiesteróide desidrogenase tipo 5, composição farmacêutica, inibidor de 17ß-hidroxiesteróide desidrogenase tipo 5, processo para inibir 17ß-hidroxiesteróide desidrogenase tipo 3, inibidor de 17ß-hidroxiesteróide desidrogenase tipo 3, processos para tratar, ou reduzir o risco de desenvolver, câncer da próstata, hiperplasia prostática benigna, acne, seborréia, hirsutismo ou alopécia androgênica, sìndrome de ovário policìstico, câncer de mama, endometriose ou leiomioma, para inibir as secreções hormonais testiculares, para tratar puberdade precoce, e, kit |
| US6268356B1 (en) | 1998-04-20 | 2001-07-31 | Pharmaceutical Resources, Inc. | Flocculated suspension of megestrol acetate |
| US6028065A (en) * | 1998-04-20 | 2000-02-22 | Pharmaceutical Resources, Inc. | Flocculated suspension of megestrol acetate |
| US6656505B2 (en) | 2000-07-21 | 2003-12-02 | Alpharma Uspd Inc. | Method for forming an aqueous flocculated suspension |
| US20030198679A1 (en) * | 2000-11-08 | 2003-10-23 | Kundu Subhas C. | Flocculated pharmaceutical suspensions and methods for actives |
| CN106109435B (zh) * | 2016-07-09 | 2018-11-06 | 南京臣功制药股份有限公司 | 一种醋酸甲地孕酮胶囊及其制备方法 |
| CN106137993B (zh) * | 2016-08-09 | 2018-11-09 | 南京臣功制药股份有限公司 | 一种醋酸甲地孕酮分散片及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH236309A (de) * | 1940-02-20 | 1945-01-31 | Chem Ind Basel | Verfahren zur Darstellung eines ,ss; , -zweifach ungesättigten Ketons. |
| US2311102A (en) * | 1940-02-20 | 1943-02-16 | Ciba Pharm Prod Inc | Doubly unsaturated ketones and process of making same |
| US2900382A (en) * | 1952-06-28 | 1959-08-18 | Syntex Sa | Method of making delta4,6 steroid compounds from delta4 steroid compounds |
| US2882282A (en) * | 1957-07-17 | 1959-04-14 | Pfizer & Co C | Method of producing 3-keto-delta4, 6-steroid compounds from 3-keto a-ring saturated 6-dihydro steroid compounds |
| US2891079A (en) * | 1959-01-23 | 1959-06-16 | Searle & Co | 6-methyl-4, 6-pregnadiene-3, 20-dione and 17alpha-acyloxy derivatives thereof |
-
1958
- 1958-11-04 GB GB35428/58A patent/GB870286A/en not_active Expired
-
1959
- 1959-10-27 US US848917A patent/US3356573A/en not_active Expired - Lifetime
- 1959-10-29 DE DEB55336A patent/DE1120446B/de active Pending
- 1959-11-02 CH CH8015259A patent/CH379493A/de unknown
- 1959-11-02 FR FR809052A patent/FR1333711A/fr not_active Expired
- 1959-11-04 BE BE584312A patent/BE584312A/fr unknown
-
1960
- 1960-08-31 FR FR837319A patent/FR970M/fr active Active
-
1964
- 1964-12-30 MY MY75/64A patent/MY6400075A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BE584312A (fr) | 1960-05-04 |
| US3356573A (en) | 1967-12-05 |
| DE1120446B (de) | 1961-12-28 |
| CH379493A (de) | 1964-07-15 |
| FR970M (h) | 1961-12-04 |
| FR1333711A (fr) | 1963-08-02 |
| GB870286A (en) | 1961-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY267A (en) | Improvements in or relating to herbicides | |
| MY6400075A (en) | Improvements in or relating to 6-methyl-3-oxo-delta 4,6-steroid compounds | |
| AU221782B2 (en) | Improvements in or relating to substituted phenoselenazine compounds | |
| AU235653B2 (en) | Improvements in or relating to novel 3, 5-diketo-pyrazolidine derivatives | |
| AU230109B2 (en) | Improvements in or relating to polyphosphates | |
| AU231562B2 (en) | Improvements in or relating to substituted trifluoromethoxy-and trifluoromethylmercaptophenothiazines | |
| AU222777B2 (en) | Improvements in or relating to bottle-crating machines | |
| AU226898B2 (en) | Improvements in or relating to narrow fabrics | |
| AU218905B2 (en) | Improvements in or relating to pulverisers | |
| AU230578B2 (en) | Improvements in or relating to relifasable cqlplings | |
| AU226561B2 (en) | Improvements in or relating to tenderometers | |
| AU225369B2 (en) | Improvements in or relating to reflex-klystrons | |
| AU224448B2 (en) | Improvements in or relating to electronmicroscopes | |
| AU218904B2 (en) | Improvements in or relating to pulverisers | |
| AU3426258A (en) | Improvements in or relating to substituted phenoselenazine compounds | |
| AU222183B2 (en) | Improvements in or relating to article-dispensing mechanisms | |
| AU234088B2 (en) | Improvements in or relating to brushware | |
| AU4190558A (en) | Improvements in or relating to novel 3, 5-diketo-pyrazolidine derivatives | |
| AU228683B2 (en) | Improvements in or relating to molecularbeam'devices | |
| AU224362B2 (en) | Improvements in or relating to melt-spinning | |
| AU4338758A (en) | Improvements in or relating to polyphosphates | |
| AU227591B2 (en) | Improvements in or relating to filaments | |
| AU226774B2 (en) | Improvements in or relating to drilling machines | |
| AU3860158A (en) | Improvements in or relating to substituted trifluoromethoxy-and trifluoromethylmercaptophenothiazines | |
| AU3682758A (en) | Improvements in or relating to bottle-crating machines |